Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt (Q37763265)
Jump to navigation
Jump to search
scientific article published on 02 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt |
scientific article published on 02 June 2010 |
Statements
1 reference
Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt (English)
1 reference
Ayalew Tefferi
1 reference
Elena Mishchenko
1 reference
2 June 2010
1 reference
1 reference
85
1 reference
3
1 reference
192-199
1 reference
Identifiers
1 reference
1 reference